ASN51

ASN-51 · Asceneuron S.A.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ASN51, covering 2024-12-18 to 2025-06-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of ASN51 in Adults With Early Alzheimer's Disease [Phase 2]